NCT07772505

Brief Summary

: Patient Information Sheet and Informed Consent Form PATIENT INFORMATION SHEET AND INFORMED CONSENT FORM (for adult subjects and interventional studies)

  • You will first be examined on your nose condition by using a scope.
  • The size of your turbinates will be documented.
  • You will be given a set of questionnaire regarding your nose condition to fill up
  • Your nose will be sprayed on either side, 2 puffs each of the decongestant spray.
  • You will be given painkiller via injections over the inner side of your nose
  • Cotton with medication will be inserted into your nose for 5 minutes
  • Either 1 of the procedures will b performed
  • After the procedure, you will be monitored for 15 minutes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 17, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2022

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

1.2 years

First QC Date

July 16, 2026

Last Update Submit

August 13, 2026

Conditions

Keywords

Radiofrequency AblationTurbinate LateralizationTurbinate OutfractureTurbinatesNasal Surgical ProceduresOffice-Based SurgeryLocal Anesthesia

Outcome Measures

Primary Outcomes (1)

  • Primary outcome measures

    1\. Change in Nasal Obstruction Symptom Evaluation (NOSE) Score Description: The total NOSE score ranges from a minimum of 0 to a maximum of 100 points on a scale, where higher scores indicate worse nasal obstruction (a more severe symptom burden). A successful outcome is defined as a reduction in score from a moderate/extreme level to a mild level. Measure Type: Mean Unit of Measure: score on a scale (0-100) Time Frame: Baseline, 1 week, 1 month, 3 months and 6 months post-procedure

    Baseline, 1 week, 1 month, 3 months and 6 months post-procedure

Secondary Outcomes (1)

  • Secondary outcome measures

    Baseline, 1 week, 1 month, 3 months, 6 months post-procedure

Study Arms (2)

Radiofrequency ablation

ACTIVE COMPARATOR

Patients with bilateral inferior turbinates hypertrophy who underwent radiofrequency ablation of inferior turbinates

Device: Radiofrequency ablation of inferior turbinates

Lateralization of inferior turbinates

ACTIVE COMPARATOR

Patients with bilateral inferior turbinates who underwent lateralization of inferior turbinates

Device: Lateralization of inferior turbinates

Interventions

Both are office procedures that can be done in clinic and we would like to determine the effectiveness of both.

Radiofrequency ablation

Lateralization of inferior turbinates with freer elevator

Lateralization of inferior turbinates

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bilateral inferior turbinate hypertrophy, Grade 3 or 4 (25% Inferior Turbinate Classification System) Age more than 18 years NOSE score more than 30 On conventional pharmacological therapy for more than 3 months

You may not qualify if:

  • Severe deviated nasal septum or caudal dislocation Nasal polyposis Nasal valve disorder Allergy or contraindication to Marcaine (bupivacaine) with adrenaline, or to Co-Phenylcaine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tengku Ampuan Rahimah Hospital

Klang, Selangor, 41200, Malaysia

Location

MeSH Terms

Conditions

Nasal Obstruction

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesAirway ObstructionRespiratory InsufficiencyRespiration DisordersOtorhinolaryngologic Diseases

Study Officials

  • Liang Chye Goh, MBBS, MS ORL HNS

    University of Malaya

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
* Patients will be allocated a number on registering for the research, such as (001,002,003,…180). By using the research randomixer online, participants will be randomly assigned to either group 1 or group 2. * Photographs of the inferior turbinates will be taken before and after procedures during each visit. The photographs will be assessed by 3 different surgeons, and the surgeons will not be informed on whether it is pre or post procedure. (outcome assessment blinding) * There should be no breaking of the randomization code as the end point accessors are the patients themselves.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: To compare the effectiveness of lateralization Vs Radiofrequency Ablation for patients with bilateral inferior turbinate hypertrophy Randomized Comparative Study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

July 16, 2026

First Posted

August 19, 2026

Study Start

November 17, 2020

Primary Completion

January 17, 2022

Study Completion

June 17, 2022

Last Updated

August 19, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

to protect patients' anonymity and privacy

Locations